Form 4: eHealth Director Erin Russell Receives Annual Equity Award of 34,574 Restricted Stock Units
Insider Transaction Report
eHealth, Inc. Director Erin L. Russell was granted 34,574 Restricted Stock Units (RSUs) as part of her annual compensation, aligning her interests with shareholders.
Summary
- Erin L. Russell, a Director of eHealth, Inc. (EHTH), acquired 34,574 shares of Common Stock on June 17, 2025, through an RSU award.
- The transaction was an acquisition (Code A) at a price of $0 per unit, indicating an equity grant.
- Following this transaction, Ms. Russell beneficially owns a total of 115,037 shares of eHealth Common Stock.
- These RSUs represent a contingent right to receive one share of common stock upon vesting.
- The RSUs will vest in four equal quarterly installments starting from June 17, 2025, contingent on Ms. Russell's continued service as a Service Provider.
- Accelerated vesting will occur on the day immediately prior to the Issuer's next annual stockholder meeting or upon a Change in Control, subject to continued service.
Sentiment
Score: 7
Explanation: The document reports a routine equity award to a director, which is a positive for aligning management interests with shareholders but does not indicate significant new financial performance or strategic shifts.
Positives
- The grant of Restricted Stock Units to a non-employee director aligns the director's long-term interests with those of the company's shareholders.
- This is a standard form of compensation for non-employee directors, indicating continuity in corporate governance practices.
Future Outlook
The RSUs are set to vest in four equal quarterly installments from June 17, 2025, subject to the director's continued service. Accelerated vesting conditions include the day prior to the next annual stockholder meeting or a Change in Control.
Industry Context
The granting of Restricted Stock Units (RSUs) to non-employee directors is a common practice across various industries, including the healthcare technology and insurance brokerage sectors where eHealth operates. This method of compensation is widely used to attract and retain qualified board members while aligning their financial incentives with the long-term performance of the company.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) for non-employee director compensation is a standard practice observed across publicly traded companies, including peers in the health insurance marketplace and digital health sectors.
- Companies like SelectQuote, Inc. (SLQT) and GoHealth, Inc. (GOCO) also utilize equity-based compensation, including RSUs, for their non-employee directors to foster alignment with shareholder interests and promote long-term value creation.
- The vesting schedule, typically over one year or tied to annual meetings, is consistent with common industry benchmarks for such awards.
Stakeholder Impact
- Shareholders: The RSU award aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
Next Steps
- The RSUs will vest in four equal quarterly installments from June 17, 2025, subject to continued service.
- Potential accelerated vesting prior to the Issuer's next annual stockholder meeting or upon a Change in Control.
Key Dates
| Date | Description |
|---|---|
| 06/17/2025 | Date of earliest transaction and vesting commencement date for the RSU award. |
| 06/20/2025 | Date the Form 4 was signed by Sonwha Lee as attorney-in-fact for Erin L. Russell. |
Keywords
eHealth, EHTH, SEC Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, RSU Award, Equity Incentive Plan, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.